The Atlas Arteria Group (ASX: ALX) share price is in focus today after the company released its second supplementary target's statement, reiterating that securityholders should reject the takeover offer from IFM's Diamond Infraco 1 Pty Ltd. Key points include confirmation of a 40c per security distribution guidance for 2026 and the continued unanimous recommendation by independent directors to reject the offer.
Image source: Getty Images
What did Atlas Arteria report?
- The offer period for IFM's off-market takeover bid has been extended by one week, now closing at 7.00pm (Sydney) on 18 June 2026.
- Atlas Arteria maintains guidance for an ordinary distribution of 40.0 cents per security in 2026.
- The independent directors continue to recommend that securityholders reject the $4.75 and $5.10 per security offers.
- No announced increase in the bidder's voting power since extension; acceptances remain low.
- The bidder has not satisfied or waived any of the extensive conditions set out in its offer.
What else do investors need to know?
The company's second supplementary target's statement was released in response to the Fourth Supplementary Bidder's Statement from IFM. The Board states there is no urgency for securityholders to accept the bid, as IFM must give notice of its offer conditions at least seven days before closure.
Atlas Arteria confirms that the proceeds from any asset sales would be available to be returned to securityholders, in addition to its regular distribution schedule. The company encourages investors to seek independent financial advice and read all issued statements and expert reports before making decisions regarding the offer.
What's next for Atlas Arteria?
Atlas Arteria's directors restate their confidence in the company's long-term value, urging securityholders to remain patient. The company has emphasised ongoing discipline in capital management, pledging returns to securityholders through regular and special distributions as circumstances permit.
With the offer period extended, investors will have advance notice if the bid becomes unconditional. The Board will continue to keep shareholders updated as developments unfold in the takeover process.
Atlas Arteria share price snapshot
Over the past 12 months, Atlas Arteria shares have declined 5%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.
